Skip to content

Dr. Raf Celus

Active Private limited companyfounded 2022active for 3 yearsSint-Jansberg 50, 3680 MaaseikKBO/BCE: BE 0795.100.486

Annual accounts 2025

micro format, filed on 01-04-2026, 121 days before the deadline
€227,281
▲ 7.0%
€211,533
▲ 7.5%
€162,696
▲ 14.2%
€349,500
▲ 91.9%
94.5%
▲ 6.3 percentage points
15.10
▲ 8.93

Turnover is estimated at about €410,000, probably between €330,000 and €520,000. The micro format does not state turnover.

Balance sheet

balance sheet total €449,436 on 31-12-2025
What the company ownsHow it is paid for

in euro

in euro

Position in the sector

94.5%

Higher than 91% of the 21,373 companies filing micro accounts in human health (NACE 86) in 2025.

15.10

Higher than 89% of the 20,922 companies filing micro accounts in human health (NACE 86) in 2025.

36.2%

Higher than 72% of the 21,223 companies filing micro accounts in human health (NACE 86) in 2025.

Dr. Raf Celus Middle half of the sector 80% of the sector Micro accounts in human health (NACE 86)

Net result: top quarter · Equity: top quarter · Balance sheet total: middle half · Working capital: top quarter

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend202520242023
226,594209,839173,241
177,757155,481130,084
10,4302,733102,659
321,092-103,471-
349,500182,17367,431
94.5%88.1%50.4%
15.106.171.85
0.060.130.98
38.3%54.4%98.3%
36.2%47.9%49.6%
74.4460.4447.66

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend202520242023
Balance sheet: assets
20/58 449,436297,203237,019
21/28 75,14079,77190,028
21 62,50075,00087,500
22/27 12,6404,7712,528
23 7,8903,7861,423
24 3,272--
26 1,4789851,105
29/58 374,296217,432146,991
40/41 2,885267-
41 2,885267-
50/53 -160,000-
54/58 344,70323,611127,082
490/1 26,70833,55419,909
Balance sheet: equity and liabilities
10/49 449,436297,203237,019
10/15 424,640261,944119,453
10/11 2,0002,0002,000
13 422,640259,944117,453
133 422,640259,944117,453
17/49 24,79635,259117,566
42/48 24,79635,25979,560
44 2,076113-
440/4 2,076113-
45 10,88525,40714,522
450/3 10,88525,40714,522
47/48 11,8359,73965,038
492/3 --38,006
Income statement
76A -342-
9900 227,281212,331180,281
630 15,06112,99012,631
640/8 6872,4927,040
9901 211,533196,849160,610
75/76B 5,819--
75 5,819--
65/66B 3,0443,4723,635
65 3,0443,4723,635
9903 214,308193,377156,975
67/77 51,61250,88639,522
9904 162,696142,491117,453
9905 162,696142,491117,453
Appropriation of the result
9906 162,696142,491117,453
691/2 162,696142,491117,453
6921 162,696142,491117,453
Document PDFPDFPDF

The full notes are in the filed accounts (PDF).

Source: Annual accounts 2025 (PDF), filed on 01-04-2026.

Download as CSV

Filings

each dot is a set of accounts, on the day it reached the National Bank
Financial year Type Filed Reference Document
31-12-2025 micro format 01-04-2026 2026-00069264 PDF
31-12-2024 micro format 20-07-2025 2025-00289552 PDF
31-12-2023 micro format 02-10-2024 2024-00488363 PDF

Investments

fixed assets acquired
Item202520242023
Tangible fixed assets€10,430€2,733€2,659
Intangible fixed assets--€100,000
€15,061€12,990€12,631

Source: notes to the 2023 to 2025 annual accounts (statement of fixed assets)

Insights on Dr. Raf Celus

The operating result for 2025 is 7% higher than in 2024 and the highest since 2023. It is the second rise in a row.

Debt's share of the balance-sheet total falls from 11.9% to 5.5%. Equity is higher and debt is lower.

Next steps